Views & Analysis Living with DMD: Inspiring each other’s futures Diagnosed with Duchenne muscular dystrophy (DMD) at three years old, Dr Jon Hastie grew up n
News Drug price controversies hit pharma's reputation Patient groups slam pharma over drug costs in latest survey.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
